542 related articles for article (PubMed ID: 32810888)
1. Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study.
Cento V; Alteri C; Mancini V; Gatti M; Lepera V; Mazza E; Moioli MC; Merli M; Colombo J; Orcese CA; Bielli A; Torri S; Gasparini LE; Vismara C; De Gasperi A; Brioschi P; Puoti M; Cairoli R; Lombardi G; Perno CF
Mycoses; 2020 Dec; 63(12):1299-1310. PubMed ID: 32810888
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of 1,3-beta-D-glucan serum screening in patients receiving hematopoietic stem cell transplantation.
Reischies FM; Prattes J; Woelfler A; Eigl S; Hoenigl M
Transpl Infect Dis; 2016 Jun; 18(3):466-70. PubMed ID: 26992092
[TBL] [Abstract][Full Text] [Related]
3. Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections.
Verma N; Singh S; Taneja S; Duseja A; Singh V; Dhiman RK; Chakrabarti A; Chawla YK
Liver Int; 2019 Mar; 39(3):503-513. PubMed ID: 30276951
[TBL] [Abstract][Full Text] [Related]
4. Comparative accuracy of 1,3 beta-D glucan and galactomannan for diagnosis of invasive fungal infections in pediatric patients: a systematic review with meta-analysis.
Singh S; Singh M; Verma N; Sharma M; Pradhan P; Chauhan A; Jaiswal N; Chakrabarti A; Singh M
Med Mycol; 2021 Feb; 59(2):139-148. PubMed ID: 32448907
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Values and Limitations of (1,3)-β-D-Glucans and Galactomannan Assays for Invasive Fungal Infection in Patients Admitted to Pediatric Intensive Care Unit.
Zheng F; Zha H; Yang D; Deng J; Zhang Z
Mycopathologia; 2017 Apr; 182(3-4):331-338. PubMed ID: 27664106
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre.
Singh S; Kaur H; Choudhary H; Sethi S; Malhotra P; Gupta KL; Rudramurthy SM; Chakrabarti A
Indian J Med Microbiol; 2018; 36(4):557-563. PubMed ID: 30880706
[TBL] [Abstract][Full Text] [Related]
7. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
[TBL] [Abstract][Full Text] [Related]
8. Detecting Invasive Fungal Disease in Surgical Patients: Utility of the (13)- β-d-Glucan Assay.
Skubic J; Taghavi S; Castillo-Angeles M; Ramsis R; Salim A; Askari R
Surg Infect (Larchmt); 2020 Jun; 21(5):461-464. PubMed ID: 31895667
[No Abstract] [Full Text] [Related]
9. Clinical evaluation of two different (1,3)-ß-d-glucan assays for diagnosis of invasive fungal diseases: A retrospective cohort study.
Zubkowicz M; Held J; Baier M; Pletz MW; Kesselmeier M; Hagel S; Bahrs C
Mycoses; 2021 Feb; 64(2):212-219. PubMed ID: 33156525
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two β-D-glucan assays for detecting invasive fungal diseases in immunocompromised patients.
Song J; Kim S; Park J; Park Y; Kim HS
Diagn Microbiol Infect Dis; 2021 Sep; 101(1):115415. PubMed ID: 34082306
[TBL] [Abstract][Full Text] [Related]
11. Detection of β-D-glucan for the diagnosis of invasive fungal infection in children with hematological malignancy.
Guitard J; Tabone MD; Senghor Y; Cros C; Moissenet D; Markowicz K; Valin N; Leverger G; Hennequin C
J Infect; 2016 Dec; 73(6):607-615. PubMed ID: 27452196
[TBL] [Abstract][Full Text] [Related]
12. (1→3)-β-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people.
White SK; Schmidt RL; Walker BS; Hanson KE
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009833. PubMed ID: 32693433
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the (1,3)-β-D-glucan assay for the diagnosis of neonatal invasive yeast infections.
Cornu M; Goudjil S; Kongolo G; Leke A; Poulain D; Chouaki T; Sendid B
Med Mycol; 2018 Jan; 56(1):78-87. PubMed ID: 28371838
[TBL] [Abstract][Full Text] [Related]
14. A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-β-D-glucan for invasive fungal infection: Focus on cutoff levels.
He S; Hang JP; Zhang L; Wang F; Zhang DC; Gong FH
J Microbiol Immunol Infect; 2015 Aug; 48(4):351-61. PubMed ID: 25081986
[TBL] [Abstract][Full Text] [Related]
15. (1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies.
Azoulay E; Guigue N; Darmon M; Mokart D; Lemiale V; Kouatchet A; Mayaux J; Vincent F; Nyunga M; Bruneel F; Rabbat A; Bretagne S; Lebert C; Meert AP; Benoit D; Pene F
Oncotarget; 2016 Apr; 7(16):21484-95. PubMed ID: 26910891
[TBL] [Abstract][Full Text] [Related]
16. β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study.
Hanson KE; Pfeiffer CD; Lease ED; Balch AH; Zaas AK; Perfect JR; Alexander BD
PLoS One; 2012; 7(8):e42282. PubMed ID: 22879929
[TBL] [Abstract][Full Text] [Related]
17. Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery.
Prattes J; Hoenigl M; Rabensteiner J; Raggam RB; Prueller F; Zollner-Schwetz I; Valentin T; Hönigl K; Fruhwald S; Krause R
Mycoses; 2014 Nov; 57(11):679-86. PubMed ID: 25040144
[TBL] [Abstract][Full Text] [Related]
18. Detection of (1→3)-β-D-glucan in same-day urine and serum samples obtained from patients with haematological malignancies.
Raggam RB; Fischbach LM; Prattes J; Duettmann W; Eigl S; Reischies F; Wölfler A; Rabensteiner J; Prueller F; Krause R; Hoenigl M
Mycoses; 2015 Jul; 58(7):394-8. PubMed ID: 25959065
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever.
Ellis M; Al-Ramadi B; Finkelman M; Hedstrom U; Kristensen J; Ali-Zadeh H; Klingspor L
J Med Microbiol; 2008 Mar; 57(Pt 3):287-295. PubMed ID: 18287290
[TBL] [Abstract][Full Text] [Related]
20. Usage of 1,3-β-D-Glucan for Early Detection of Invasive Mycoses and Outcome Parameter in Immunocompromised Critically Ill Patients.
Lahmer T; Held J; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
Mycopathologia; 2016 Dec; 181(11-12):815-821. PubMed ID: 27619810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]